Hideki Amemiya
- Hepatology top 5%
- Liver physiology and pathology 5
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Gastroenterology top 10%
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 3
- Lymphatic System and Diseases 2
-
- Immune Cell Function and Interaction 4
- Reproductive Medicine top 10%
-
- Clinical Nutrition and Gastroenterology 3
-
- Digestive system and related health 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
Hideki Amemiya
17 papers receiving 660 citations
Peers
Comparison fields: 5 of 50
- Hepatology 124
- Gastroenterology 65
- Oncology 277
- Immunology 142
- Reproductive Medicine 53
Countries citing papers authored by Hideki Amemiya
This map shows the geographic impact of Hideki Amemiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Amemiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Amemiya more than expected).
Fields of papers citing papers by Hideki Amemiya
This network shows the impact of papers produced by Hideki Amemiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Amemiya. The network helps show where Hideki Amemiya may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Hideki Amemiya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Increased expression of the c-Met receptor mRNA in gastric cancer]. | 2013 | 2 |
| 2 | [Role of the expression of c-Met receptor in the progression of gastric cancer]. | 2010 | 10 |
| 3 | 2004 | 12 | |
| 4 | 2003 | 19 | |
| 5 | 2003 | 55 | |
| 6 | 2002 | 117 | |
| 7 | 2002 | 52 | |
| 8 | 2002 | 84 | |
| 9 | Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial. | 2002 | 80 |
| 10 | 2001 | 20 | |
| 11 | 2001 | 14 | |
| 12 | 2001 | 61 | |
| 13 | Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer. | 2001 | 49 |
| 14 | 2000 | 73 | |
| 15 | 2000 | 21 | |
| 16 | 1999 | 1 | |
| 17 | 1999 | 6 |
About Hideki Amemiya
Hideki Amemiya is a scholar working on Hepatology, Oncology and Nutrition and Dietetics, having authored 17 papers that have together received 676 indexed citations. Recurring topics across this work include Liver physiology and pathology (5 papers), Immune Cell Function and Interaction (4 papers), Clinical Nutrition and Gastroenterology (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Digestive system and related health (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Lymphatic System and Diseases (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Hepatology (124 citations), Gastroenterology (65 citations) and Oncology (277 citations). Hideki Amemiya has collaborated with scholars based in Japan and Venezuela. Frequent co-authors include Koji Kono, Akihiro Takahashi, Yoshirô Matsumoto, Hidehiko Iizuka, Hideki Fujii, Fumiko Ichihara, Takayoshi Sekikawa, Hideki Fujii, Jun Itakura and Rui Tang. Their work appears in journals such as International Journal of Cancer, Journal of Gastroenterology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.